TAZICEF (Hospira, Inc.)
Welcome to the PulseAid listing for the TAZICEF drug offered from Hospira, Inc.. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | CEFTAZIDIME |
SUBSTANCE NAME: | CEFTAZIDIME |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1986-03-06 |
END MARKETING DATE: | 0000-00-00 |
TAZICEF HUMAN PRESCRIPTION DRUG Details:
Item Description | TAZICEF from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(g/1) |
START MARKETING DATE: | 1986-03-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-5086_c6cda305-b695-4111-8826-199b53022535 |
PRODUCT NDC: | 0409-5086 |
APPLICATION NUMBER: | ANDA062662 |
Other CEFTAZIDIME Pharmaceutical Manufacturers / Labelers: